• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Intuitive's da Vinci 5 Surgical System Receives CE Mark

    7/2/25 9:46:50 AM ET
    $ISRG
    Industrial Specialties
    Health Care
    Get the next $ISRG alert in real time by email

    SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark approval for adult and pediatric use in Europe for minimally invasive endoscopic procedures across abdominopelvic and thoracoscopic surgical procedures, including urologic, gynecologic, and general laparoscopic procedures.

    Da Vinci 5 is Intuitive's most advanced and integrated multiport robotic-assisted surgical system, building on the da Vinci Xi Surgical System's highly functional design.

    It features more than 150 enhancements and joins a portfolio of da Vinci surgical systems that surgeons have used in more than 410,000 procedures in Europe in 2024 and nearly 17 million procedures worldwide to date.

    "We are pleased that our da Vinci 5 Surgical System has received CE mark approval, marking its entry to Europe," said Intuitive Chief Executive Officer Dave Rosa.

    "At Intuitive, we're focused on providing healthcare systems across Europe and around the world with thoughtful innovation that solves problems today and into the future.  After over a decade of careful development, da Vinci 5 is the most advanced and integrated platform we've ever created – designed to enable better outcomes, efficiency, and insights for the future of minimally invasive care," said Rosa.

    Da Vinci 5 is designed to deliver:

    • Enhanced surgical senses to support better patient outcomes, including first-of-its-kind Force Feedback enabled technology, the most realistic 3D da Vinci vision system to date, and an ergonomic, immersive surgeon console to support surgeon career longevity.
    • Operational efficiency, through greater surgeon autonomy with the integration of key components that surgeons can control at their fingertips, and by streamlining workflow with an easy-to-learn system, a universal user interface for care teams, and dynamic assistance integrated into the system to automate select tasks.
    • Actionable insights through an intelligent platform with 10,000x more computing power and new sensors, software, and advanced processors – providing surgeons with more useable data to help them quantify, understand, and improve their surgical performance for patients.

    "We believe that the operational efficiencies and actionable insights provided by da Vinci 5 will not only help transform surgery but also help address critical challenges faced by healthcare systems across Europe," said Dirk Barten, Intuitive senior vice president and general manager for Europe.

    "It's exciting that surgeons and care teams across Europe will have their choice of the full portfolio of da Vinci systems, including da Vinci 5, giving them greater choice and flexibility, and ultimately supporting quality care for more patients across the region," said Barten.

    In 2024, the U.S. Food and Drug Administration cleared the da Vinci 5 Surgical System for use during urology, general, gynecology, and thoracic procedures in adults.

    Da Vinci 5 is the fifth generation da Vinci surgical system and the latest addition to the da Vinci family. This includes multiport systems da Vinci X and da Vinci Xi, and the single port system da Vinci SP, offering surgeons and hospitals their choice of highly capable, proven solutions from Intuitive.

    2025 marks Intuitive's 30th year developing robotic-assisted technology with the goal of improving patient outcomes, improving patient and care team experience, increasing access to minimally invasive care, and lowering the total cost to treat. In Intuitive's first three decades, surgeons have performed nearly 17 million procedures using our technology and nearly 90,000 surgeons have been trained to use our systems worldwide.

    Contact 

    Megan Elliott, Intuitive

    (669) 222-9899

    [email protected]

    About Intuitive Surgical, Inc.

    Intuitive (NASDAQ:ISRG), headquartered in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery. Our technologies include the da Vinci surgical system and the Ion endoluminal system. By uniting advanced systems, progressive learning, and value-enhancing services, we help physicians and their teams optimize care delivery to support the best outcomes possible. At Intuitive, we envision a future of care that is less invasive and profoundly better, where disease is identified early and treated quickly, so that patients can get back to what matters most.

    For more information, please visit: http://www.intuitive.com/safety

    About da Vinci surgical systems

    There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery and offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialised instrumentation, including a miniaturised surgical camera and wristed instruments (i.e., scissors, scalpels, and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

    Forward-Looking Statements

    This press release contains forward-looking statements which relate to expectations concerning matters that are not historical facts. Statements using words such as "estimates," "projects," "believes," "anticipates," "plans," "expects," "intends," "may," "will," "can," "could," "should," "would," "targeted," "potential," and similar words and expressions are intended to identify forward-looking statements. These forward-looking statements are necessarily estimates reflecting the judgment of Intuitive's management and involve a number of risks and uncertainties that could cause actual results or impacts on its operations, financial performance, and business position to differ materially from those suggested by the forward-looking statements. These forward-looking statements include, but are not limited to, statements related to research and development of products and services, manufacturing of products, obtaining of regulatory approvals, technical, clinical, and other performance of products and services, and making products and services available to more patients and health care professionals. These forward-looking statements should be considered in light of various important factors and involve known and unknown risks, uncertainties, and other factors, which may cause the actual results, performance, or achievements of Intuitive, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements include, among others, economic conditions in the geographic markets in which we operate, changes in governmental regulations, regulatory approval priorities, resources, and timelines, regulatory enforcement priorities, governmental investigations and civil litigation, and other factors discussed in Intuitive's Annual Reports and other filings with relevant securities regulators.

    Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release and which are based on current expectations and are subject to risks, uncertainties, and assumptions that are difficult to predict, including those risk factors identified under the heading "Risk Factors" in Intuitive's Annual Report on Form 10-K for the year ended December 31, 2024, as updated by its other filings with the U.S. Securities and Exchange Commission. Intuitive's actual results may differ materially and adversely from those expressed in any forward-looking statements, and it undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.



    Primary Logo

    Get the next $ISRG alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ISRG

    DatePrice TargetRatingAnalyst
    6/9/2025$440.00Hold → Sell
    Deutsche Bank
    6/5/2025Hold → Buy
    Erste Group
    12/2/2024$522.00 → $650.00Equal-Weight → Overweight
    Morgan Stanley
    8/2/2024$380.00 → $510.00Neutral → Buy
    Redburn Atlantic
    7/10/2024$462.00 → $512.00Buy
    Citigroup
    5/30/2024$500.00Buy
    Goldman
    11/17/2023$318.00Buy
    HSBC Securities
    7/19/2023$377.00Outperform
    Robert W. Baird
    More analyst ratings

    $ISRG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Intuitive Surgical downgraded by Deutsche Bank with a new price target

      Deutsche Bank downgraded Intuitive Surgical from Hold to Sell and set a new price target of $440.00

      6/9/25 7:47:07 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical upgraded by Erste Group

      Erste Group upgraded Intuitive Surgical from Hold to Buy

      6/5/25 7:52:11 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical upgraded by Morgan Stanley with a new price target

      Morgan Stanley upgraded Intuitive Surgical from Equal-Weight to Overweight and set a new price target of $650.00 from $522.00 previously

      12/2/24 6:57:53 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Intuitive's da Vinci 5 Surgical System Receives CE Mark

      SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the da Vinci 5 Surgical System has received CE mark approval for adult and pediatric use in Europe for minimally invasive endoscopic procedures across abdominopelvic and thoracoscopic surgical procedures, including urologic, gynecologic, and general laparoscopic procedures. Da Vinci 5 is Intuitive's most advanced and integrated multiport robotic-assisted surgical system, building on the da Vinci Xi Surgical System's highly functional design. It features more than 150 enhancements and joins a

      7/2/25 9:46:50 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • 30 years of Innovation and Impact: Dan Larson's Inspiring Story

      SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

      5/27/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces CEO Transition Effective July 1, 2025

      President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

      5/15/25 9:05:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    SEC Filings

    See more
    • SEC Form 144 filed by Intuitive Surgical Inc.

      144 - INTUITIVE SURGICAL INC (0001035267) (Subject)

      6/10/25 4:01:41 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

      5/15/25 9:05:20 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - INTUITIVE SURGICAL INC (0001035267) (Filer)

      5/5/25 9:00:20 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President Rosa David J. converted options into 1,358 shares and covered exercise/tax liability with 674 shares, increasing direct ownership by 0.30% to 231,756 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      6/10/25 12:36:53 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SVP & Chief Mfg and Supply Cha Brosius Mark sold $242,182 worth of shares (431 units at $561.91), decreasing direct ownership by 32% to 907 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      6/6/25 4:20:59 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • President Rosa David J. gifted 851 shares, decreasing direct ownership by 0.37% to 231,072 units (SEC Form 4)

      4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

      6/4/25 6:53:25 PM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Leadership Updates

    Live Leadership Updates

    See more
    • 30 years of Innovation and Impact: Dan Larson's Inspiring Story

      SUNNYVALE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- When Seattle resident Dan Larson was diagnosed with lung cancer in 2023, his only exposure to robotic technology was through his work as a quality engineer at Boeing. He could never have imagined that robotic technology made by Intuitive, the pioneer of robotic-assisted surgery, would one day play a pivotal role in his health care. Having experienced the loss of his father to lung cancer, Dan was determined to overcome his own diagnosis and enjoy his retirement with his family. Under the care of clinicians at MultiCare Tacoma General Hospital in Washington, Dan underwent two robotic lung biopsies with the Ion Endoluminal System, Intuit

      5/27/25 9:15:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces CEO Transition Effective July 1, 2025

      President Dave Rosa promoted to CEOCurrent CEO Gary Guthart to become executive chair of Intuitive's boardCurrent Board Chair Craig Barratt to become lead independent director SUNNYVALE, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced the promotion of President Dave Rosa to chief executive officer, effective July 1, 2025. At that time, current CEO Gary Guthart will become the executive chair of Intuitive's board of directors, and current Board Chair Craig Barratt will become lead independent director. Guthart will work closely with Rosa to support a smooth t

      5/15/25 9:05:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, March 7, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, March 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 100 are more representative of the mega-cap market space. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P

      3/7/25 6:19:00 PM ET
      $ALK
      $AMBC
      $ATI
      $BBWI
      Air Freight/Delivery Services
      Consumer Discretionary
      Property-Casualty Insurers
      Finance

    $ISRG
    Financials

    Live finance-specific insights

    See more
    • Intuitive Announces First Quarter Earnings

      SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March 31, 2025. Q1 Highlights Worldwide da Vinci procedures grew approximately 17% compared with the first quarter of 2024.The Company placed 367 da Vinci surgical systems, compared with 313 in the first quarter of 2024. The first quarter 2025 da Vinci surgical system placements included 147 da Vinci 5 systems, compared with 8 in the first quarter of 2024.The Company grew its da Vinci surgical system installed base to 10,189 systems as of Mar

      4/22/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces Fourth Quarter Earnings

      SUNNYVALE, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended December 31, 2024. Q4 Highlights Worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.The Company placed 493 da Vinci surgical systems, compared with 415 in the fourth quarter of 2023. The fourth quarter 2024 da Vinci surgical system placements included 174 da Vinci 5 systems.The Company grew its da Vinci surgical system installed base to 9,902 systems as of December 31, 2024, an increase of 15%

      1/23/25 4:05:00 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • Intuitive Announces Preliminary Fourth Quarter and Full Year 2024 Results

      SUNNYVALE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Intuitive (the "Company") (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced certain unaudited preliminary fourth quarter and full year 2024 financial results ahead of its presentation at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025. Financial and Operational Highlights Fourth quarter 2024 worldwide da Vinci procedures grew approximately 18% compared with the fourth quarter of 2023.Full year 2024 worldwide da Vinci procedures grew approximately 17% compared with 2023. The Company expects worldwide da Vinci procedures to i

      1/15/25 9:00:00 AM ET
      $ISRG
      Industrial Specialties
      Health Care

    $ISRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/14/24 10:02:59 AM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/14/23 12:37:59 PM ET
      $ISRG
      Industrial Specialties
      Health Care
    • SEC Form SC 13G/A filed by Intuitive Surgical Inc. (Amendment)

      SC 13G/A - INTUITIVE SURGICAL INC (0001035267) (Subject)

      2/9/23 11:22:22 AM ET
      $ISRG
      Industrial Specialties
      Health Care